Though it is a cannabis component, very high doses of CBD don’t appear to affect driving, a small Australian study reports. Researchers from the University of Sydney found that even 1,500 mg, the highest daily medicinal dose of cannabidiol (CBD) tested, did not seem to affect study participants’ thinking skills or driving when tested in… read on > read on >
A little about: Weekly Sauce
All Sauce from Weekly Sauce:
Abbott to Re-Open Baby Formula Plant on June 4
Beginning June 4, Abbott Nutrition will restart producing baby formula at a shuttered factory that’s been central to the ongoing shortage of infant formula in the United States, the company announced on Tuesday. The factory in Sturgis, Mich., has been closed since February for what the U.S. Food and Drug Administration called “insanitary conditions.” In… read on > read on >
Effectiveness of Antiviral Drugs Against Monkeypox Uncertain: Study
Up until recently monkeypox infection outside of Africa was rare, but a look back at seven cases occurring in Britain over the past few years gives hints at what drugs work to fight the disease — and which don’t. The need to better understand treatments for monkeypox became more urgent this month when more than… read on > read on >
Another Study Finds Kids of Same-Sex Parents Do Just Fine
Children raised by same-sex parents are just as well-adjusted as kids raised by different-sex parents, researchers say. In the new study, the researchers compared 62 Dutch children (aged 6 to 16 years) whose parents were the same sex with 72 kids whose parents were different sexes. The investigators considered prosocial behavior, hyperactivity, peer problems, emotional… read on > read on >
Long-Term Heart Inflammation Strikes 1 in 8 Hospitalized COVID Patients
A year after being hospitalized with COVID-19, more than 12% of patients had been diagnosed with heart inflammation, according to a new study of the long-term effects of the virus. For the study, researchers in Scotland followed 159 patients hospitalized with COVID-19 between May 2020 and March 2021. A year later, many patients had ongoing… read on > read on >
Use Pot? You May Need More Sedation During Endoscopies
If you use pot, you may need more sedation than normal during a gastric endoscopy, according to a new study. “Patients didn’t have increased awareness or discomfort during procedures, but they did require more drugs,” lead author Dr. Yasmin Nasser said in a news release from the American Gastroenterological Association. Nasser is an assistant professor… read on > read on >
Prostate Cancer May Raise Risk for Blood Clots
Doctors need to be aware that prostate cancer raises a man’s risk of serious and potentially deadly blood clots by about 50%, researchers say. All cancer patients are at increased risk for venous thromboembolism (VTE), a dangerous but treatable blood clot in the veins that is a leading cause of death in cancer patients. Prostate… read on > read on >
Colon Cancer Death Rates Are Falling Among the Young — But Only for Whites
Race and ethnicity matter when battling colon cancer, with young white patients facing notably better odds than Black, Hispanic or Asian patients, new research warns. A look at colon cancer survival among Americans younger than 50 turned up a glaring discrepancy: Survival five years after diagnosis improved to nearly 70% among white patients over two… read on > read on >
Medical Marijuana May Offer Safe Pain Relief for Cancer Patients
Cancer patients who use medical marijuana experience less pain and a better quality of life, Israeli researchers report. And, their new study found, these patients were able to rely less on opioid painkillers, with minimal side effects. “I hope people pay attention to the results of this study and use cannabis when appropriate for patients… read on > read on >
COVID Can ‘Rebound’ After Treatment With Paxlovid, CDC Says
COVID-19 can make a comeback after an infected person has gone through a round of Paxlovid, the antiviral used to minimize a bout with the coronavirus, according to an advisory issued Tuesday by the U.S. Centers for Disease Control and Prevention. “Recent case reports document that some patients with normal immune response who have completed… read on > read on >